CC
LMAT icon

Corton Capital’s LeMaitre Vascular LMAT Stock Holding History

Corton Capital’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,217
Closed -$296K – 303
2024
Q4 		$296K Buy
+3,217
New +$309K 0.17% 105

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Corton Capital's LMAT Position: Q1 2025 in Review

Corton Capital sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 3,217 shares — an estimated $296K sold.

Corton Capital first reported a position in LMAT in Q4 2024 and held it in 1 quarter. The position peaked at $296K in Q4 2024. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • Corton Capital reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
  • Corton Capital sold 3,217 LeMaitre Vascular shares in Q1 2025, an estimated $296K.
  • Corton Capital first reported a position in LeMaitre Vascular in Q4 2024 and held it in 1 quarter.
  • Corton Capital's LeMaitre Vascular position peaked at $296K in Q4 2024.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on Corton Capital's 13F filing for Q1 2025, filed 7 May 2025.